Dietrich Léna G, Grobbelaar Adriaan O, Lese Ioana
Department of Plastic and Hand Surgery, Inselspital, University Hospital, University of Bern, 3012 Bern, Switzerland.
J Clin Med. 2025 Aug 5;14(15):5510. doi: 10.3390/jcm14155510.
: Peripheral nerve injuries, especially involving the facial nerve, present unique reconstructive challenges due to their complex functional demands and limited regenerative potential. While autografts remain the gold standard, their drawbacks-such as donor-site morbidity and limited availability-have driven interest in processed nerve allografts. Acellular grafts, in particular, offer promising off-the-shelf alternatives without the need for immunosuppression. : We conducted a narrative review of the literature (1990-2023), identifying 55 peer-reviewed studies via PubMed, Embase, and Cochrane Library. The studies included clinical and preclinical work on motor nerve regeneration using processed nerve allografts, with particular attention to outcomes in facial nerve repair. Two independent reviewers conducted abstract screening, full-text review, and data extraction. : Processed nerve allografts show encouraging motor recovery in gaps under 50 mm, with recovery rates of up to 85% reported. Outcomes decrease significantly in longer gaps (>50-60 mm) and in complex cases, including facial nerve repairs, where evidence remains sparse and largely extrapolated from broader motor nerve data. Registry data (e.g., RANGER) support their use but are limited by heterogeneity and lack of randomization. : Processed nerve allografts represent a viable alternative to autografts in selected cases-especially short to mid-length motor nerve defects. However, their role in facial nerve reconstruction remains insufficiently studied. Further trials are needed to address specific anatomical and functional challenges in this subgroup and to clarify long-gap efficacy.
周围神经损伤,尤其是涉及面神经的损伤,由于其复杂的功能需求和有限的再生潜力,带来了独特的重建挑战。虽然自体移植仍然是金标准,但其缺点,如供体部位的发病率和可用性有限,促使人们对处理过的神经同种异体移植产生兴趣。特别是脱细胞移植物提供了有前景的现成替代品,无需免疫抑制。
我们对文献(1990 - 2023年)进行了叙述性综述,通过PubMed、Embase和Cochrane图书馆确定了55项经同行评审的研究。这些研究包括使用处理过的神经同种异体移植进行运动神经再生的临床和临床前工作,特别关注面神经修复的结果。两名独立评审员进行了摘要筛选、全文审查和数据提取。
处理过的神经同种异体移植在50毫米以下的间隙中显示出令人鼓舞的运动恢复,报告的恢复率高达85%。在更长的间隙(>50 - 60毫米)和复杂病例中,包括面神经修复,结果显著下降,在这些病例中证据仍然稀少,且大多是从更广泛的运动神经数据推断而来。登记数据(如RANGER)支持它们的使用,但受到异质性和缺乏随机化的限制。
在某些情况下,特别是短至中等长度的运动神经缺损,处理过的神经同种异体移植是自体移植的可行替代方案。然而,它们在面神经重建中的作用仍研究不足。需要进一步试验来解决该亚组中的特定解剖和功能挑战,并阐明长间隙疗效。